The largest holder of Leonardo Drs stock is Leonardo S.P.A., with 189.7 million shares (71.09% of the company), worth about $7.21 billion as of September 25, 2026. The 10 largest holders together own 83.1%.
In Q2 2026, 397 institutional holdings reports listed 74.9 million shares worth $3.12 billion, up 8.9% in shares from Q1 2026.
Insiders reported 77 transactions in the last two years: 39 sales worth $19.58 million and no purchases. The newest one on file is from April 2, 2026 (Dorfman Mark A., General Counsel).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through April 2, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Leonardo S.P.A. | 189.7 million | 71.09% | $7.2B |
| BlackRock Advisors LLC | 4.6 million | 1.73% | $176.0M |
| State Street Corporation | 4.5 million | 1.69% | $172.0M |
| AQR Capital Management LLC | 4.4 million | 1.66% | $168.0M |
| Vanguard Portfolio Management LLC | 3.6 million | 1.35% | $137.0M |
| Vanguard Capital Management LLC | 3.6 million | 1.34% | $136.0M |
| Fidelity Management & Research Co. LLC | 3.5 million | 1.30% | $132.0M |
| First Trust Advisors LP | 2.7 million | 1.00% | $102.0M |
| T. Rowe Price International Ltd. | 2.5 million | 0.95% | $97.0M |
| Voya Investment Management Co. LLC | 2.5 million | 0.94% | $96.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 397 | 74.9 million | $3.1B |
| Q1 2026 | 361 | 68.8 million | $3.1B |
| Q4 2025 | 336 | 69.2 million | $2.4B |
| Q3 2025 | 341 | 67.7 million | $3.1B |
| Q2 2025 | 337 | 65.5 million | $3.1B |
| Q1 2025 | 270 | 69.5 million | $2.3B |
| Q4 2024 | 263 | 68.7 million | $2.2B |
| Q3 2024 | 222 | 68.9 million | $1.9B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Dorfman Mark A. | Apr 2, 2026 | General Counsel | Sale at price 45.38 per share. | $211,425 |
| Wallace Sally | Apr 2, 2026 | Chief Operating Officer | Sale at price 46.35 per share. | $1.3M |
| Dippold Michael | Apr 2, 2026 | Chief Financial Officer | Sale at price 45.38 per share. | $320,882 |
| Dorfman Mark A. | Apr 1, 2026 | General Counsel | -- | – |
| Baylouny John | Apr 1, 2026 | Chief Executive Officer | -- | – |
| Townsend Frances Fragos J.D. | Apr 1, 2026 | Director | -- | – |
| Wallace Sally | Apr 1, 2026 | Chief Operating Officer | -- | – |
| Morrow Pamela | Apr 1, 2026 | Officer | -- | – |
| Dippold Michael | Apr 1, 2026 | Chief Financial Officer | -- | – |
| Rinsky Jason | Apr 1, 2026 | Officer and Treasurer | -- | – |
| Dorfman Mark A. | Apr 1, 2026 | General Counsel | Stock Award(Grant) at price 0.00 per share. | – |
| Baylouny John | Apr 1, 2026 | Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 77 insider transactions in the last two years.
Leonardo S.P.A., with 71.09% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (1.73%) and State Street Corporation (1.69%).
397 institutional holdings reports listed Leonardo Drs shares in Q2 2026, 74.9 million shares in all worth $3.12 billion.
In the last two years insiders reported 39 sales and no purchases (77 transactions in all); the newest on file is from April 2, 2026.